For the Inventor, By the Inventor

Enter assignee name

Nucryst Pharmaceuticals Corp.

USPTO Granted Patents = 15

% Expired Patents = 33.3

CIPO Patents = 1

Trademarks = 1

Forward Citations = 592

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Robert Edward Burrell (11 out of 30 patents)

Paul Schechter (6 out of 6 patents)

Scott H Gillis (6 out of 7 patents)

4. Hua Qing Yin (6 out of 6 patents)

5. Antony George Naylor (4 out of 4 patents)

6. Peter Howard Moxham (4 out of 4 patents)

7. Kan Lam (3 out of 4 patents)

8. John Barrymore Wright (3 out of 4 patents)

9. James Alexander Robert Stiles (2 out of 12 patents)

10. Katherine Jane Turner (1 out of 16 patents)

11. Jeffrey B Lyczak (1 out of 1 patent)

12. Katherine Thompson (1 out of 1 patent)

13. Stojan Djokic (1 out of 6 patents)

14. Walter Carlton Theodore Cholowski (1 out of 1 patent)

15. Leonard Salvin Bowlby (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 8425880 - Metal-containing materials for treatment of bacterial conditions (2013-04-23),

2. 7470437 - Methods of treating conditions with a metal-containing material (2008-12-30),

3. 7427416 - Methods of treating conditions using metal-containing materials (2008-09-23),

4. 7255881 - Metal-containing materials (2007-08-14),

5. 7137968 - Transcutaneous medical device dressings and method of use (2006-11-21),

6. 7087249 - Treatment of mucosal membranes (2006-08-08),

7. 7078060 - Solutions and aerosols of metal-containing compounds (2006-07-18),

8. 7008647 - Treatment of acne (2006-03-07),

9. 6989157 - Dry powders of metal-containing compounds (2006-01-24),

10. 6989156 - Therapeutic treatments using the direct application of antimicrobial metal compositions (2006-01-24),

11. 6939568 - Treatment of inflammatory skin conditions (2005-09-06),

12. 6723350 - Lubricious coatings for substrates (2004-04-20),

13. 6719987 - Antimicrobial bioabsorbable materials (2004-04-13),

14. 6692773 - Treatment of hyperproliferative skin disorders and diseases (2004-02-17),

15. 6365220 - Process for production of actively sterile surfaces (2002-04-02),

Nucryst Pharmaceuticals Corp. is a biotechnology company based in Fort, CA, specializing in the development of advanced medical technologies. The company focuses on innovative solutions for wound care and infection management, leveraging proprietary materials and formulations. Nucryst's research emphasizes the application of nanotechnology and antimicrobial agents to enhance healing processes and improve patient outcomes. With a commitment to addressing unmet medical needs, Nucryst aims to deliver effective therapies in the healthcare sector.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

15 Patents

#4 in Fort

#983 in Canada

#39,881 in the World

Nucryst Pharmaceuticals Corp.

Forward Citations = 592

18 inventors:

Robert Edward Burrell (11 out of 30 patents)

Paul Schechter (6 out of 6 patents)

Scott H Gillis (6 out of 7 patents)

4. Hua Qing Yin (6 out of 6 patents)

5. Antony George Naylor (4 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…